The deal is expected to be one of the largest settlements against an opioid manufacturer, with funds for victims.

The deal could end a years-long legal battle over the OxyContin maker's role in the US opioid crisis.

Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm